After legalisation, who owns the plant?

Legalisation can free
the plant from prison and still
hand it to a boardroom.

That is the uncomfortable lesson cannabis reform must be mature enough to face. A legal market is not automatically a fair market. A licensed product is not automatically an accessible product. A regulated industry is not automatically a diverse one.

For decades, cannabis lived under prohibition: hidden, punished, romanticised, contaminated, exploited and misunderstood. Legalisation was supposed to bring the plant into the light. In many ways, it did. Testing improved. Patients gained access. Consumers entered safer shops. Farmers, processors, retailers and educators could finally speak in public without pretending the subject did not exist.

That matters.
It should not be dismissed.

But reform does not end when the police step back. A different question begins:
who is allowed to survive the legal market?

Because legality has costs. Licensing costs. Compliance costs. Lawyers. Real estate. Security. Seed-to-sale tracking. Taxes. Packaging rules. Banking obstacles. Insurance. Delayed openings. Local bans. Political uncertainty. Price compression. Competition from the illegal market. Competition from larger legal operators. The plant may be legal, but the gate around the plant can still be very expensive.

If compliance is so expensive that only giants survive,
legality becomes another kind of exclusion.

This is where cannabis education must be careful. It should not fall into childish anti-business theatre. Large companies are not automatically villains. Some build laboratories, create jobs, stabilise supply, support patient access and raise quality standards. A serious cannabis culture should be able to recognise good work wherever it comes from.

But the opposite mistake is just as dangerous. Sponsorship is not innocence. Capital is not education. A polished brand deck is not a public-interest policy. A company can produce clean medicine and still benefit from a market structure that quietly eliminates smaller competitors.

A sponsor is not a sin.
A hidden agenda is the problem.

The danger is not business itself. The danger is capture.

Capture happens when reform keeps the language of justice but gives the structure of the market to those already best positioned to pay for entry. It happens when social equity exists on paper but applicants cannot access capital. It happens when craft growers are celebrated in speeches and destroyed by tax bills. It happens when patients are promised access but prices remain close to the illicit market. It happens when the old underground is invited to provide authenticity, then priced out of participation.

The small grower should not be romanticised. Small does not automatically mean ethical, clean, skilled or community-minded. The illegal market produced its own greed, contamination, violence and stupidity. Nostalgia is not a quality-control system.

But the small grower should not be erased either.

Cannabis knowledge did not come only from corporations, laboratories or regulators. It came from patients, breeders, gardeners, smugglers, herbalists, activists, underground publishers, risk-takers, sick people, stubborn people and people who had no legal language available for what they were doing. Some of that history is messy. Some of it is embarrassing. Some of it is precious.

Legalisation that destroys this diversity
does not simply clean the market.
It thins the memory of the plant.

The question, then, is not whether cannabis should be regulated. Of course it should. People deserve tested products, honest labels, safe access, age controls, medical clarity and environmental responsibility. The opposite of bad regulation is not no regulation. It is better regulation.

The question is
whether regulation protects the public or protects the gate.

A healthy cannabis market should make room for different scales: medical producers, craft farms, co-operatives, social clubs where allowed, patient growers, research suppliers, small retailers, community-based operators, responsible larger companies and serious educators. Not every model belongs everywhere. Not every country needs to copy California, Canada, Germany, Spain or the Netherlands. But every country should ask the same hard question before the market is designed:

Does this system create access,
or does it merely create permission
for those who can afford permission?

This matters especially when education and sponsorship meet. Cannabis projects need money. Events need partners. Publications need support. Research needs funding. Pretending otherwise is childish.

But education must keep its spine.

A sponsor may support a project. A sponsor must not own the conclusions. A company may be featured. It must also be questioned. A product may be useful. It must not become scripture. If a brand cannot survive fair scrutiny, it does not belong near education.

Good partners should welcome informed readers.
Bad partners prefer obedient audiences.

This is the line LIBERA HERBA must hold: not anti-company, not anti-profit, not anti-growth — but anti-capture. Pro-transparency. Pro-testing. Pro-small operator where small operators are serious. Pro-patient. Pro-craft where craft means competence, not costume. Pro-market diversity. Pro-accountability.

The end of prohibition is not the end of power.
It is a change in who is allowed to hold it.

Cannabis reform must choose:
diversity of access or concentration of ownership.

If legalisation forgets the small grower, the patient, the local culture, the independent educator and the communities harmed by prohibition, then the plant has not truly been freed. It has only changed rooms.

The plant left the cell.
Now we must watch who locks the next door.